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 Introduction 
 Regulation of mRNA turnover plays an essential role in modu-
lating gene expression ( Meyer et al., 2004 ;  Parker and Song, 
2004 ;  Garneau et al., 2007 ). For all major paths of mRNA decay 
yet recognized in mammalian cells, including mRNA decay di-
rected by AU-rich elements (AREs) in the 3  untranslated re-
gion ( Chen and Shyu, 1995 ), decay mediated by destabilizing 
elements in protein-coding regions ( Grosset et al., 2000 ;  Chang 
et al., 2004 ), nonsense-mediated decay (NMD;  Chen and Shyu, 
2003 ), decay directed by microRNAs (miRNAs;  Wu et al., 2006 ), 
and decay of stable mRNAs such as   -globin mRNA ( Yamashita 
et al., 2005 ), the fi rst major step is deadenylation. 
 Mammalian deadenylation is mediated by the concerted 
action of two different poly(A) nuclease complexes ( Yamashita 
et al., 2005 ). Poly(A) tails are fi rst shortened to   110 nt by 
Pan2 in association with Pan3. In the second phase of deadenyl-
ation, a complex composed of Ccr4 and Caf1 catalyze further 
shortening of the poly(A) tail to oligo(A). Decapping by the 
Dcp1 – Dcp2 complex ( Lykke-Andersen, 2002 ;  van Dijk et al., 
2002 ;  Wang et al., 2002 ;  Piccirillo et al., 2003 ) may occur dur-
ing and/or after the second phase of deadenylation ( Yamashita 
et al., 2005 ). Although Pan3 and Caf1 associate with Pan2 and 
Ccr4 poly(A) nucleases, respectively ( Brown et al., 1996 ;  Albert 
et al., 2000 ;  Tucker et al., 2001 ;  Temme et al., 2004 ;  Uchida 
et al., 2004 ), their in vivo roles in mammalian mRNA turnover 
remain unclear. In yeast, Pan3 does not exhibit poly(A) nucle-
ase activity but its association with Pan2 is required for proper 
function of Pan2 ( Brown et al., 1996 ;  Mangus et al., 2004 ). 
In vitro experiments using recombinant human Pan2 and Pan3 
proteins ( Uchida et al., 2004 ) suggest that Pan3 plays a role 
in enhancing the poly(A) nuclease activity of Pan2 in mamma-
lian cells. However, ectopic overexpression of Pan2 alone in 
mouse NIH3T3 cells results in highly rapid and processive 
deadenylation of an otherwise stable reporter mRNA or a pre-
mature translation-termination codon (PTC) – containing mRNA 
( Yamashita et al., 2005 ), indicating that Pan3 is not required for 
the nuclease activity of Pan2 for mammalian mRNA turnover. 
Instead, Pan3 may modulate the activity of Pan2 poly(A) nucle-
ase or link deadenylation to subsequent decay of the mRNA 
body. Unlike Pan3, Caf1 exhibits poly(A) nuclease activity 
( Daugeron et al., 2001 ;  Dupressoir et al., 2001 ;  Temme et al., 
2004 ;  Bianchin et al., 2005 ;  Molin and Puisieux, 2005 ). How-
ever, studies in yeast show that Caf1 poly(A) nuclease activity 
per se is not required for general deadenylation in vivo, although 
the presence of Caf1 is necessary for proper deadenylation by 
 Deadenylation is the major step triggering mamma-lian mRNA decay. One consequence of deadenyl-ation is the formation of nontranslatable messenger 
RNA (mRNA) protein complexes (messenger ribonucleo-
proteins [mRNPs]). Nontranslatable mRNPs may accumulate 
in P-bodies, which contain factors involved in translation 
repression, decapping, and 5  -to-3  degradation. We demon-
strate that deadenylation is required for mammalian 
P-body formation and mRNA decay. We identify Pan2, 
Pan3, and Caf1 deadenylases as new P-body compo-
nents and show that Pan3 helps recruit Pan2, Ccr4, and 
Caf1 to P-bodies. Pan3 knockdown causes a reduction of 
P-bodies and has differential effects on mRNA decay. 
Knocking down Caf1 or overexpressing a Caf1 catalyti-
cally inactive mutant impairs deadenylation and mRNA 
decay. P-bodies are not detected when deadenylation is 
blocked and are restored when the blockage is released. 
When deadenylation is impaired, P-body formation is not 
restorable, even when mRNAs exit the translating pool. 
These results support a dynamic interplay among deadenyl-
ation, mRNP remodeling, and P-body formation in selec-
tive decay of mammalian mRNA.
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functions in deadenylation crucial for P-body formation? Is de-
adenylation a prerequisite for P-body formation? In this paper, we 
address these questions by examining the subcellular localiza-
tion and functions of poly(A) nucleases and their cofactors in 
relation to the formation of P-bodies and mRNA turnover in 
mammalian cells. 
 Results 
 Pan2 and Pan3 are components 
of P-bodies 
 We fi rst determined whether Pan2 and Pan3, the factors involved 
in initiating mammalian mRNA deadenylation ( Uchida et al., 2004 ; 
 Yamashita et al., 2005 ), are found in P-bodies of mouse NIH3T3 
fi broblasts (the cell line used for monitoring mRNA decay kinetics 
by the well-established transcriptional pulsing system;  Xu et al., 
1998 ;  Chen et al., 2007 ). Dcp1a, a well-characterized compo-
nent of P-bodies which is necessary for mRNA decapping in 
 eukaryotes ( Beelman et al., 1996 ;  Lykke-Andersen, 2002 ;  Cougot 
et al., 2004 ;  Kedersha et al., 2005 ), was used as a marker to visu-
alize P-bodies by immunofl uorescence microscopy. Both endog-
enous Dcp1a and ectopically expressed Dcp1a fused with green 
fl uorescent protein (GFP-Dcp1a) distributed in a focal pattern 
that disappeared upon translation blockage by cycloheximide in 
NIH3T3 cells (Fig. S1, available at http://www.jcb.org/cgi/content/
full/jcb.200801196/DC1), as expected for P-bodies ( Andrei et al., 
2005 ;  Brengues et al., 2005 ;  Ferraiuolo et al., 2005 ). The results 
show that cytoplasmic foci detected by an anti-Pan2 antibody 
colocalize with P-bodies either marked by GFP- Dcp1a ( Fig. 1 A ) 
or detected by an anti-Dcp1a antibody ( Fig. 1 B , top). [I D]FIG1[/ID] Upon cyclo-
heximide treatment, neither P-bodies nor Pan2 foci were detected 
( Fig. 1 B , bottom). These results indicate that Pan2 is a compo-
nent of P-bodies. 
 We further substantiated this fi nding by showing that Pan2 
foci colocalize with P-bodies in COS7 cells, using both Dcp1a 
and Xrn1 as markers to visualize P-bodies ( Fig. 1 C , top and mid-
dle). Moreover, the endogenous Pan3 also distributes in cyto-
plasmic foci that colocalize with the Pan2 foci in COS7 cells 
( Fig. 1 C , bottom). Because of lack of an anti-Pan3 antibody suit-
able for immunofl uorescence microscopy of mouse NIH3T3 cells, 
DNA coding for HA-Pan3 (HA-tagged Pan3) was delivered into 
NIH3T3 cells via transient transfection. Our data show that HA-
Pan3 also distributes in a focal pattern colocalized with P-bodies 
( Fig. 1 D ). It is worth noting that the number of P-bodies increased 
appreciably when HA-Pan3 was overexpressed ( Fig. 1 D ), sug-
gesting a role of Pan3 in initiating or enhancing the formation of 
P-bodies. The HA-Pan3 foci are not stress granules, as they can 
be detected regardless of whether or not the cells were treated 
with arsenite (Fig. S2, available at http://www.jcb.org/cgi/content/
full/jcb.200801196/DC1), a cellular stress inducer ( Kedersha et al., 
2002 ). Stress granules were only found in the arsenite-treated 
cells, as visualized by a stress granule marker G3BP1 (Fig. S2, 
bottom), and not in cells without arsenite treatment (Fig. S2, top). 
Importantly, when stress granules were induced, they did not co-
localize with the HA-Pan3 foci (Fig. S2, bottom, right). Collec-
tively, our results identify both Pan2 and Pan3 as being two new 
components of P-bodies in mammalian cells. 
Ccr4 ( Viswanathan et al., 2004 ). In contrast, the major poly(A) 
nuclease activity in  Drosophila melanogaster resides in the 
Ccr4 – Caf1 complex, with depletion of Caf1 exerting a stronger 
impeding effect than depletion of Ccr4 on deadenylation ( Temme 
et al., 2004 ). Mammalian Caf1 has also been shown to display 
poly(A) nuclease activity in vitro ( Viswanathan et al., 2004 ; 
 Bianchin et al., 2005 ), but the role of Caf1 in mammalian mRNA 
turnover remains unclear. 
 Recent studies have revealed the existence of specifi c cyto-
plasmic foci, known as RNA P-bodies (processing bodies), that 
contain proteins with known functions in mRNA metabolism 
(for reviews see  Eulalio et al., 2007b ;  Kedersha and Anderson, 
2007 ;  Parker and Sheth, 2007 ). These foci are also referred to as 
GW bodies because they carry GW182 proteins that are required 
for miRNA-mediated translation repression (for reviews see 
 Ding and Han, 2007 ;  Eulalio et al., 2007b ). Translationally re-
pressed mRNA protein complexes (mRNPs), factors which are 
involved in translational repression including miRNA-mediated 
translational silencing proteins (such as Argonaute proteins and 
Rck/p54), decapping enzymes, and a 5  -to-3  exonuclease Xrn1, 
are also found in these foci (for reviews see  Eulalio et al., 2007b ; 
 Kedersha and Anderson, 2007 ;  Parker and Sheth, 2007 ). Thus, 
recent studies of P-bodies have mainly focused on the roles 
of decapping and translation repression in P-body formation. 
The relationship of these P-body – related machineries to dead-
enylation, the fi rst step triggering mRNA decay, and the roles of 
deadenylation factors in P-body formation remain largely un-
clear. Besides, owing to the power of yeast and  D. melanogaster 
genetics, the participating factors and their roles in eukaryotic 
P-body formation and mRNA turnover were largely identifi ed 
by studies in yeast and  D. melanogaster . Little was known about 
these important issues in mammalian cells. 
 In wild-type yeast strain under normal growth conditions, 
neither endogenous Ccr4 – Caf1 (or Pop2) complex nor ectopi-
cally expressed Ccr4 form any discernable foci that colocalize 
with P-bodies ( Sheth and Parker, 2003 ;  Teixeira and Parker, 
2007 ). Although Ccr4 and Pop2 can be localized in P-bodies in 
mutant yeast strains with xrn1 or dcp1 gene deleted ( Teixeira 
and Parker, 2007 ), defects in Ccr4p and Pop2p do not signifi -
cantly affect P-body formation and composition ( Teixeira and 
Parker, 2007 ). In  D. melanogaster , the Ccr4 – Caf1 complex was 
also found in cytoplasmic foci ( Temme et al., 2004 ), but whether 
those foci are P-bodies or not was not addressed. The only 
mammalian poly(A) nuclease that has been shown to localize 
in P-bodies is Ccr4 ( Cougot et al., 2004 ;  Andrei et al., 2005 ). 
Although knocking down Ccr4 in HeLa cells can lead to loss of 
P-bodies ( Andrei et al., 2005 ), the effect of Ccr4 knockdown on 
deadenylation in these cells was not addressed. Thus, it is not 
clear as to whether P-body loss caused by knocking down Ccr4 
is because of the impairment of deadenylation or simply be-
cause of the absence of the Ccr4 protein molecule that may be 
physically important for the structural integrity of P-bodies. 
Therefore, the role of deadenylation factors in P-body forma-
tion and the relationship between deadenylation and P-body 
formation in mammalian cells remain unknown. For example, 
are Pan2, Pan3, and Caf1 also present in P-bodies like Ccr4? 
Are these factors necessary for P-body formation, and are their 
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colocalize with P-bodies in HEK293 cells ( Cougot et al., 2004 ), 
ectopically expressed Ccr4 and Caf1 did not form foci that co-
localized with P-bodies in NIH3T3 cells, regardless of whether 
they were overexpressed separately ( Fig. 2, C [top and middle] 
 and D [top, left]) or together ( Fig. 2 C , bottom). Because Pan3 
is able to enhance localization of Pan2 to P-bodies ( Fig. 2 A ), 
we then tested whether Pan3 also helps Ccr4 and Caf1 localize 
to P-bodies. After coexpressing HA-Pan3 with GFP-Ccr4 ( Fig. 
2 D , top, right) or Caf1-V5 ( Fig. 2 D , bottom), we observed that 
both proteins distributed in a focal pattern colocalized with the 
P-bodies. These experiments show that Pan3 also enhances lo-
calization of Ccr4 and Caf1 to P-bodies. 
 Pan3 knockdown affects P-body formation 
and has differential effects on mRNA decay 
 The fi ndings in the previous sections ( Figs. 1 [D] and 2 ) suggest 
that Pan3 plays a critical role in mammalian P-body formation. 
We knocked down Pan3 in NIH3T3 cells using siRNAs and ex-
amined the effects on P-body formation ( Fig. 3 A ). [ID]FIG3 [/ID] Immuno-
fl uorescence microscopy revealed a reduction of P-bodies in 
cells treated with Pan3-specifi c siRNAs but not in cells treated 
with control siRNAs ( Fig. 3 A , top and middle). Western blot-
ting analysis indicated that an   80% knockdown effi ciency was 
achieved ( Fig. 3 A , bottom). These experiments demonstrate 
that Pan3 not only is an integral component of P-bodies but also 
is important for the formation of P-bodies. 
 We next examined the effect of Pan3 knockdown on 
mRNA deadenylation and decay in NIH3T3 cells. Decay of a 
nonsense-containing mRNA (BBB+PTC), a c- fos ARE-containing 
mRNA (BBB+ARE), and the stable   -globin (BBB) message, 
representing three distinct pathways, was tested. The transcripts 
were expressed under the control of an inducible Tet-off promoter 
 Pan3 helps Pan2, Ccr4, and Caf1 localize 
to P-bodies 
 Although Pan2 and Pan3 can form a complex in the cytoplasm, 
the fi nding that HA-Pan3 can be detected in P-bodies when it 
is overexpressed alone ( Fig. 1 D ) suggests that Pan3 can asso-
ciate with P-bodies without a coordinated expression of Pan2. 
In contrast, ectopically expressed Pan2 did not distribute in a 
focal pattern when expressed alone ( Fig. 2 A , top and middle) 
but did colocalize with P-bodies when coexpressed with HA-Pan3 
( Fig. 2 A , bottom). [ID]FIG2[/ID] In contrast, ectopically expressed myc-PABP, 
a non – P-body component ( Kedersha et al., 2005 ) which has the 
ability to bind Pan3 ( Brown et al., 1996 ;  Mangus et al., 2004 ; 
 Uchida et al., 2004 ), displayed a uniform distribution in the cyto-
plasm without forming foci even when coexpressed with HA-Pan3 
(Fig. S3, available at http://www.jcb.org/cgi/content/full/jcb
.200801196/DC1). These results further corroborate our con-
clusion that HA-Pan3 foci correspond to P-bodies and indicate 
that Pan3 helps Pan2 localize to P-bodies. 
 As Ccr4 has been observed to colocalize with P-bodies in 
mammalian cells ( Cougot et al., 2004 ;  Andrei et al., 2005 ), we 
then tested whether Caf1 can also be found in mammalian 
P-bodies by examining subcellular localization of endogenous 
Caf1 in NIH3T3 cells ( Fig. 2 B ). Immunofl uorescence micro-
scopic results show a strong staining in both nuclei and cyto-
plasm of cells (with two to six foci colocalized with P-bodies 
marked by GW182 in each cell) when the anti-Caf1 antibody 
was used ( Fig. 2 B , top), whereas only a weak and nonspecifi c 
background staining was detected when preimmune serum was 
used ( Fig. 2 B , bottom). Thus, our data indicate that only a small 
portion of Caf1 colocalizes with P-bodies, which is similar to 
the staining patterns previously observed for Ccr4 ( Cougot et al., 
2004 ;  Andrei et al., 2005 ). Although GFP-Ccr4 was observed to 
 Figure 1.  Pan2 and Pan3 are P-body com-
ponents. (A and B) Pan2 foci colocalize with 
P-bodies in NIH3T3 cells (top) and are dis-
assembled upon cycloheximide treatment 
(B, bottom, middle), as expected for P-bodies 
(B, bottom, left). (C) Pan2 foci colocalize with 
P-bodies detected with anti-Dcp1a (top) or anti-
Xrn1 (middle) antibodies in monkey COS7 cells, 
in which Pan3 foci also colocalize with Pan2 
foci (bottom). (D) HA-Pan3 foci colocalize with 
P-bodies in NIH3T3 cells. Immunoﬂ uorescence 
staining was performed as described in Ma-
terials and methods. The original blue color 
of HA-Pan3 staining was changed to red for 
easier visualization. Bars, 15  μ m. 
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P-bodies ( Fig. 3 A ) and has differential effects on mRNA decay 
( Fig. 3 B ) suggest that different roles of Pan3 and P-bodies 
in different mRNA decay pathways exist in mammalian cells 
(see Discussion). 
 Pan2 – Pan3 and Ccr4 – Caf1 complexes can 
interact with each other in vivo 
 The observations that Pan 3 helps recruit Pan2, Ccr4, and Caf1 
to P-bodies ( Fig. 2 ) suggest that the Pan2 – Pan3 and Ccr4 – Caf1 
complexes can communicate with each other in vivo. To test 
this hypothesis, we performed a series of coimmunoprecipita-
tion/Western blotting experiments using RNase A – treated ly-
sates prepared from cells overexpressing the components of 
these complexes ( Fig. 4 ). [ID]FIG4[/ID] When HA-Pan3 was expressed alone, 
endogenous Pan2 and PABP were both coprecipitated along with 
( Lofl in et al., 1999b ;  Chen et al., 2007 ). This well-established 
promoter – reporter system allows a transcriptional pulsing for 
monitoring the deadenylation of a uniformly sized population 
of mRNA molecules, permitting evaluation of mRNA dead-
enylation and decay kinetics ( Lofl in et al., 1999b ;  Chen et al., 
2007 ).   -Globin – GAPDH hybrid mRNA, transcribed from a 
cotransfected plasmid, was constitutively expressed from an 
SV40 early promoter to serve as internal standard for trans-
fection effi ciency and sample loading. Our results show that 
knocking down Pan3 had little effect on the fi rst phase of dead-
enylation (between 0 and 1 h), but it slowed the second phase of 
deadenylation and increased the overall stability of the BBB+PTC 
mRNA ( Fig. 3 B , top). In contrast, a faster decay of BBB and 
BBB+ARE mRNAs was observed ( Fig. 3 B , middle and bottom). 
Our observations that Pan3 knockdown causes a reduction of 
 Figure 2.  Pan3 helps Pan2, Ccr4, and Caf1 localize to P-bodies. (A) Ectopically expressed Pan2 proteins do not distribute in a focal pattern when ex-
pressed alone (top and middle) but can form foci that colocalize with P-bodies when coexpressed with HA-Pan3 (bottom). NIH3T3 cells were transfected 
with a plasmid encoding GFP-Dcp1a, either together with a plasmid encoding HA-Pan2 (top) or Pan2-V5 (middle) or with both a plasmid encoding HA-
Pan3 and a plasmid encoding Pan2-V5 (bottom). Immunoﬂ uorescence staining was performed as described in Materials and methods. (B) Only a small 
portion of endogenous Caf1 can be found in foci that colocalize with P-bodies marked by GW182. Localization of endogenous GW182 or Caf1 was 
determined using human anti-GW182 serum (left) or rabbit anti-Caf1 antibody (top, middle). Rabbit preimmune serum (bottom, middle) was used as a 
control. (C) Ectopically expressed HA-Ccr4 and Caf1-V5 do not colocalize with P-bodies in NIH3T3 cells, regardless of whether they were overexpressed 
separately (top and middle) or together (bottom). (D) Ectopically expressed GFP-Ccr4 does not form foci that colocalize with P-bodies in NIH3T3 cells (top, 
left), but ectopically expressed Ccr4 and Caf1 can colocalize with P-bodies when coexpressed with HA-Pan3 (top [right] and bottom). Immunoﬂ uorescence 
staining was performed as described in Materials and methods. The original blue color of HA-Ccr4 staining in C (top) and HA-Pan3 staining in D (top, 
right) was changed to red for easier visualization. Insets show an enlarged view of the boxed regions to better depict the absence or presence of foci 
colocalized with P-bodies. Bars, 15  μ m. 
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 The notion that the Pan2 – Pan3 and Ccr4 – Caf1 complexes 
can associate with each other was further confi rmed by the re-
sults showing that Pan3-V5, endogenous Caf1, and a modest 
amount of endogenous PABP were coprecipitated with HA-
Pan2 by an anti-HA antibody when HA-Pan2 and Pan3-V5 
were coexpressed ( Fig. 4 C ). The abundant GAPDH protein, 
which served as a negative control, was not found in the precip-
itates. The modest amount of endogenous PABP in the precipi-
tate ( Fig. 4 C ) suggests an indirect association between HA-Pan2 
and PABP, presumably mediated via Pan3-V5, as HA-Pan2 
alone did not pull down PABP ( Fig. 4 B ). Because high titer 
Ccr4 and Pan3 antibodies for immunoprecipitation were un-
available, we coexpressed Ccr4-V5 and HA-Pan3 and used an 
anti-V5 antibody for coimmunoprecipitation experiments to test 
whether an interaction exists between Ccr4 and Pan3 ( Fig. 4 D ). 
Our data demonstrated a strong coprecipitation of endogenous 
Caf1 with Ccr4-V5 ( Fig. 4 D ). Moreover, a huge amount of 
HA-Pan3, as well as a modest amount of the endogenous Pan2 
and PABP, was also coprecipitated with Ccr4-V5. As a control, 
no coimmunoprecipitation of GAPDH was detected. Collec-
tively, our data support that Pan2 – Pan3 and Ccr4 – Caf1 poly(A) 
HA-Pan3 ( Fig. 4 A ). These results are consistent with previous 
fi ndings that Pan3 is a genuine PABP binding protein ( Siddiqui 
et al., 2007 ) and that Pan2 and Pan3 can form complexes in vivo 
( Mangus et al., 2004 ). In contrast, endogenous Caf1 was not 
found in the HA-Pan3 precipitate ( Fig. 4 A ), indicating a lack of 
direct interaction between Pan3 and Caf1 or an interaction too 
weak to be detected. However, when HA-Pan2 was ectopically 
expressed alone ( Fig. 4 B ), endogenous Caf1, but not PABP, 
was coprecipitated with HA-Pan2, indicating a specifi c inter-
action between Pan2 and Caf1, either directly or indirectly. 
Therefore, Pan2 – Pan3 and Ccr4 – Caf1 complexes may commu-
nicate with each other in vivo via the interaction between Pan2 
and Caf1. 
 Figure 3.  Pan3 knockdown affects P-body formation and has differential 
effects on mRNA decay. (A, left) Immunoﬂ uorescence microscopy results 
showing a signiﬁ cant loss of P-bodies in cells transfected with the Pan3-spe-
ciﬁ c siRNA (Pan3 siRNA) but not with the control nonspeciﬁ c (NS) siRNA. 
Rabbit anti-Dcp1a antibody was used to detect P-bodies. (A, bottom) A 
summary of the changes in P-body number and size after Pan3 knockdown 
(see Materials and methods). (A, right) Western blots showing that the 
Pan3 siRNA efﬁ ciently knocked down the Pan3 expression but had little 
effect on the expression of the three other P-body components (Dcp1a, 
Rck/p54, and Caf1) and the control (GAPDH). (B) Northern blots showing 
the effects of Pan 3 knockdown on deadenylation and decay of BBB+PTC 
(top), BBB+ARE (middle), or BBB (bottom) mRNA. NIH3T3 B2A2 cells were 
transiently cotransfected with a Tet promoter – regulated plasmid encoding 
a reporter mRNA as indicated and either the nonspeciﬁ c siRNA or Pan3 
siRNA. A plasmid encoding constitutively expressed   -globin – GAPDH mRNA 
was also cotransfected to provide an internal standard for transfection 
efﬁ ciency and sample handling (control). Times correspond to hours after 
tetracycline addition. Poly(A)  –  RNA was prepared in vitro by treating an 
RNA sample from an early time point with oligo(dT) and RNase H. 
 Figure 4.  Pan2 – Pan3 and Ccr4 – Caf1 complexes can interact with each 
other in vivo. COS7 cells were transfected with plasmids encoding HA-Pan3 
(A), HA Pan2 (B), HA-Pan2 and Pan3-V5 (C), or Ccr4-V5 and HA-Pan3 (D). 
RNase A – treated cell extracts were ﬁ rst subjected to immuno precipitation 
(IP) using anti-HA antibody Afﬁ nity Matrix (A – C) or anti-V5 antibody con-
jugated to agarose beads (D). Immunoprecipitates were then separated by 
SDS-PAGE and analyzed by Western blotting using the various antibodies 
indicated to the left of each panel. Input: 5% of total lysate used for immuno-
precipitation is shown for comparison. 
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These results demonstrate that Caf1 exhibits a robust poly(A) 
shortening activity that enhances the deadenylation of mRNAs 
in the cytoplasm of mammalian cells. Interestingly, ectopically 
overexpressing both Ccr4 and Caf1 had an additive effect on 
accelerating poly(A) shortening ( Fig. 6 C , bottom, left), indi-
cating that coordinated expression of both proteins further 
promotes the deadenylation function of Ccr4 – Caf1 poly(A) nu-
clease complex in NIH3T3 cells. 
 The poly(A) nuclease activities of Caf1 and 
Ccr4 have complementary roles 
in mammalian deadenylation 
 To better address the role of Caf1 in mammalian mRNA turn-
over, we took the approach of inhibiting endogenous Caf1 activ-
ity by ectopically expressing a catalytically inactive mutant of 
Caf1 and monitoring the effects on the decay of BBB+PTC, 
BBB+ARE, and BBB mRNAs in NIH3T3 cells ( Fig. 6, A and B 
[bottom, left]  and C [middle, middle]). We changed a critical as-
partate residue, which is necessary for metal binding and Caf1 
nuclease activity ( Viswanathan et al., 2004 ), to alanine by site-
directed mutagenesis to create the mutant Caf1. Northern blotting 
results show that the Caf1 mutant exhibits a profound dominant-
negative effect, blocking deadenylation of all the reporter mRNAs 
tested and leading to drastic stabilization of these transcripts. 
It is worth noting that the broad bands normally detected for the 
internal control   -globin – GAPDH hybrid message constitu-
tively transcribed from the SV40 early promoter also became 
tight and migrated much more slowly than the poly(A)  –  band. 
These observations indicate that overexpression of mutant Caf1 
has a general and very profound dominant-negative effect on 
deadenylation in mammalian cells. 
 As Caf1 and Ccr4 work as a complex ( Tucker et al., 2002 ; 
 Temme et al., 2004 ;  Behm-Ansmant et al., 2006 ) and ectopically 
overexpressing both Ccr4 and Caf1 had an additive effect on 
 accelerating poly(A) shortening ( Fig. 6 C , bottom, left), we 
then tested whether coexpressing wild-type Ccr4 can release the 
deadenylation blockage caused by the Caf1 mutant. The results 
( Fig. 6 C , bottom, middle) show that the dominant-negative effect 
exerted by the Caf1 mutant was greatly diminished when wild-
type Ccr4 was coexpressed. The deadenylation kinetics of BBB 
mRNA were now similar to those observed in cells coexpress-
ing wild-type Caf1 and Ccr4 ( Fig. 6 C , bottom, left). Thus, the 
poly(A)-shortening activity of Caf1 can be complemented by that 
of Ccr4 for deadenylation of the mRNA substrate. Previously, we 
had shown that overexpressing a dominant-negative catalytically 
inactive Ccr4 mutant slowed the deadenylation of BBB mRNA 
( Fig. 6 C , middle, left;  Yamashita et al., 2005 ). We now tested 
whether the poly(A) nuclease activity of Caf1 can also comple-
ment that of Ccr4 by coexpressing wild-type Caf1 and the Ccr4 
mutant. The results show that the deadenylation kinetics of BBB 
mRNA in the presence of both wild-type Caf1 and Ccr4 mutant 
( Fig. 6 C , bottom, right) are similar to those observed in cells co-
expressing wild-type Ccr4 and Caf1 mutant ( Fig. 6 C , bottom, 
middle) or coexpressing wild-type Ccr4 and Caf1 ( Fig. 6 C , bot-
tom, left). Collectively, we conclude that the poly(A) nuclease 
activities of Ccr4 and Caf1 in the Ccr4 – Caf1 complex have com-
plementary roles in mammalian deadenylation. 
nuclease complexes can associate with each other to form a super-
complex in vivo. 
 Caf1 is required for deadenylation and can 
accelerate poly(A) shortening in mouse 
NIH3T3 cells 
 To address the role of Caf1 in mammalian mRNA turnover, we 
fi rst determined whether mRNA deadenylation and decay re-
quires Caf1. We knocked down endogenous Caf1 in NIH3T3 cells 
by siRNA ( Fig. 5 ) and examined the effects on the deadenylation 
and decay kinetics of BBB+PTC, BBB+ARE, and BBB mRNAs. [ID]FIG5[/ID] 
As shown in  Fig. 5 , Caf1 knockdown signifi cantly impairs the 
deadenylation and decay of all the mRNAs tested, demonstrat-
ing that Caf1 plays a key role in mRNA deadenylation and decay 
in mouse NIH3T3 cells. 
 As Caf1 was shown to exhibit poly(A) nuclease activity 
in vitro ( Viswanathan et al., 2004 ;  Bianchin et al., 2005 ), we next 
tested whether Caf1 can accelerate deadenylation in vivo by 
 examining the effects of overexpressing Caf1 on deadenylation 
of BBB+PTC, BBB+ARE, and BBB mRNAs in NIH3T3 cells 
( Fig. 6 ). [ID]FIG6[/ID] Caf1 overexpression led to extremely rapid deadenyl-
ation of all the reporter mRNAs tested. Poly(A) shortening was 
detected as early as the 0-h time point ( Fig. 6, A – C , top, right). 
 Figure 5.  Caf1 is required for deadenylation. (A) Northern blots showing 
the effects of Caf1 knockdown on deadenylation and decay of BBB+PTC 
(top), BBB+ARE (middle), or BBB (bottom) mRNA. NIH3T3 B2A2 cells were 
transiently cotransfected with a Tet promoter – regulated plasmid encoding 
a reporter mRNA, as indicated, and either the control siRNA (NS siRNA) 
or Caf1 siRNA. Times correspond to hours after tetracycline addition. The 
control mRNA (ctrl) and the preparation of Poly(A)  –  RNA were as described 
in the  Fig. 3 B legend. Black lines indicate that intervening lanes have been 
spliced out. (B) Western blot showing  > 90% efﬁ ciency of Caf1 knockdown. 
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mutant Ccr4 and mutant Caf1 ( Fig. 7 B , right, dashed lines). 
Collectively, these results demonstrate that P-body formation is 
dependent on active deadenylation in mammalian cells. This con-
clusion was further substantiated by the observation that P-bodies 
were also undetectable when Caf1 was knocked down ( Fig. 8 A , 
bottom, left), a condition that also severely impaired deadenyl-
ation ( Fig. 5 ). [ID]FIG8[/ID] 
 Several previous studies have shown that both the num-
ber and size of P-bodies are increased by treating eukaryotic 
cells with the translation inhibitor puromycin, which increases 
the amount of nontranslatable mRNPs ( Cougot et al., 2004 ; 
 Maroney et al., 2006 ;  Eulalio et al., 2007a ;  Yang and Bloch, 2007 ). 
To further substantiate the fi nding that P-body formation is de-
pendent on active deadenylation, we tested whether P-body for-
mation can be induced by puromycin treatment of the cells in 
which deadenylation has already been impaired. As shown in 
 Fig. 8 , puromycin treatment increases the number and size of 
P-bodies when deadenylation is not blocked, namely in cells 
transfected with nonspecifi c siRNA ( Fig. 8 A , top, right), over-
expressing wild-type Caf1 ( Fig. 8 B , top, right, dashed line), or 
nontransfected ( Fig. 8 B , top and bottom, right, area surround-
ing the enclosed region). Strikingly, when deadenylation was 
blocked by knocking down Caf1 ( Fig. 8 A , bottom) or by over-
expressing the Caf1 dominant-negative mutant ( Fig. 8 B , bot-
tom, dashed line), puromycin treatment failed to induce P-body 
formation. These results demonstrate that P-bodies cannot form 
as long as deadenylation is impaired, even when mRNPs exit the 
translating pool. 
 P-body formation requires active 
deadenylation 
 Our fi ndings that expression of the dominant-negative HA-Caf1 
mutant completely blocked deadenylation ( Fig. 6 C , middle, 
middle) and coexpression of wild-type HA-Ccr4 released the 
deadenylation blockage ( Fig. 6 C , bottom, middle) provided an 
approach to study how alteration of deadenylation may impact 
P-body formation without knocking down any deadenylase that 
may be physically required for the structural integrity of P-bodies. 
We performed immunofl uorescence microscopy to test for the 
presence of P-bodies in cells overexpressing wild-type Caf1, 
mutant Caf1, or coexpressing the Caf1 mutant with wild-type or 
mutant Ccr4 ( Fig. 7 ). [ID]FIG7[/ID] It should be noted that without a coordi-
nated expression of Pan3, ectopically expressed Ccr4 and Caf1 
proteins did not form foci that colocalized with P-bodies ( Fig. 2 C 
and  Fig. 7 , green staining). To test the presence of P-bodies, 
endogenous Pan2 and Dcp1a were used as markers to visualize 
P-bodies. The results show that P-bodies could hardly be de-
tected in NIH3T3 cells overexpressing the Caf1 mutant ( Fig. 7 A , 
right, dashed lines), whereas overexpressing wild-type Caf1 did 
not have any obvious effect ( Fig. 7 A , left). Similar results 
were also observed in COS7 cells (Fig. S4, available at http://
www.jcb.org/cgi/content/full/jcb.200801196/DC1). Remark-
ably, P-bodies were restored when wild-type Ccr4 was co-
expressed with the Caf1 mutant ( Fig. 7 B , left), a situation in 
which the negative effect of the Caf1 mutant on deadenylation 
was mitigated ( Fig. 6 C , bottom, middle). Conversely, P bodies 
remained undetectable when cells were cotransfected with both 
 Figure 6.  The poly(A) nuclease activities of 
Caf1 and Ccr4 have complementary roles in 
deadenylation. (A and B, top and bottom, left) 
Northern blots showing the effects of over-
expressing wild-type or mutant (mut) Caf1 on 
deadenylation and decay of BBB+PTC (A) or 
BBB+ARE (B) mRNA. (A and B, bottom, right) 
Western blots showing the expression levels 
of the ectopically expressed wild-type (wt) or 
mutant HA-Caf1 proteins. (C) Northern blots 
showing the effects of overexpressing wild-type 
or mutant Ccr4 or Caf1 alone or different pairs 
of Ccr4 and Caf1 on deadenylation and de-
cay of BBB mRNA. The expression levels of the 
ectopically expressed Caf1 or Ccr4 proteins 
were analyzed by Western blotting. NIH3T3 
B2A2 cells were transiently cotransfected with 
a Tet promoter – regulated plasmid encoding a 
reporter mRNA and the plasmids encoding the 
wild-type or mutant Ccr4 or Caf1 as indicated. 
Times correspond to hours after tetracycline 
addition. The control mRNA (ctrl) and the prep-
aration of Poly(A)  –  RNA were as described in 
the  Fig. 3 B legend. Black lines indicate that 
intervening lanes have been spliced out. 
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the cytoplasm ( Chen and Shyu, 2003 ). Moreover, knocking down 
Dcp2 does not have any appreciable stabilizing effect on a PTC-
containing mRNA ( Yamashita et al., 2005 ). In the present study, 
we further show that NMD, ARE-mediated mRNA decay, and 
the default decay pathway for a stable message are all impaired 
when deadenylation is inhibited either by knocking down Caf1 
( Fig. 5 ) or by overexpressing a Caf1 dominant-negative mutant 
( Fig. 6 ). Thus, deadenylation is a necessary initial step for all 
major paths of mRNA decay yet recognized in mammalian cells, 
including NMD. 
 Deadenylation is a prerequisite and 
precursor for P-body formation 
 Several lines of evidence from this study demonstrate that de-
adenyl ation is a prerequisite and precursor for P-body formation 
in mammalian cells. First, impairment of deadenylation by 
knockdown of Caf1 ( Fig. 5 ) leads to loss of P-bodies ( Fig. 8 A ). 
 Discussion 
 Deadenylation is a necessary initial step 
in all major pathways of mammalian 
mRNA decay 
 Deadenylation is known as the fi rst major step triggering gen-
eral mRNA decay in mammalian cells ( Meyer et al., 2004 ;  Parker 
and Song, 2004 ). The importance of deadenylation for initiating 
NMD in mammalian cells is a recent insight ( Chen and Shyu, 
2003 ;  Yamashita et al., 2005 ) because previous studies in yeast 
supported a decapping-dependent NMD pathway ( Muhlrad and 
Parker, 1994 ). Several fi ndings demonstrate that mammalian NMD 
occurs in the cytoplasm and is triggered by deadenylation but 
not by decapping. A PTC at codon 39 of   -globin (BBB+PTC) 
mRNA induces accelerated deadenylation and subsequent rapid 
decay of the RNA body. Blocking translation initiation stabilizes 
the transcript, confi rming involvement of the NMD pathway in 
 Figure 7.  P-body formation requires active 
deadenylation. (A and B) Overexpression of 
catalytic mutant (mut) Caf1 blocks formation 
of P-bodies (A, right, dashed lines), and the 
blocking effect of Caf1 mut can be reversed 
by coexpressing wild-type Ccr4 (B, left) but not 
by coexpressing a catalytically inactive mutant 
of Ccr4 (B, right, dashed lines). NIH3T3 cells 
were transfected with plasmids encoding ei-
ther wild-type (A, left) or mutant (A, right) Caf1 
alone or cotransfected with plasmids encoding 
mutant Caf1 and either wild-type (B, left) or 
mutant (B, right) Ccr4. Immunoﬂ uorescence 
staining was performed as described in Materials 
and methods. The original blue color of HA-
tagged protein staining was changed to green 
for easier visualization. Endogenous Pan2 
and Dcp1a were used as markers to visualize 
P-bodies. Bars, 15  μ m. (C) Western blots show-
ing the expression levels of the ectopically 
expressed Caf1 or Ccr4 as well as the levels of 
endogenous Pan2 and Dcp1a. 
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phases of deadenylation, although they take place sequentially, 
are functionally linked ( Yamashita et al., 2005 ). Second, key 
components of both poly(A) nuclease complexes are all found 
in P-bodies ( Figs. 1 and 2 ), suggesting a direct role for them in 
P-body formation. Third, although PABP can enhance Pan2 nu-
clease activity ( Boeck et al., 1996 ;  Mangus et al., 2004 ;  Uchida 
et al., 2004 ) and can interact with Pan3 ( Fig. 4 ), PABP does not 
colocalize with P-bodies (Fig. S3;  Kedersha et al., 2005 ), sug-
gesting that the fi rst phase of deadenylation, as well as that of 
mRNP remodeling involving dissociation of PABPs, occurs 
before appearance of an mRNP in P-bodies. 
 Because PABPs are not found in P-bodies and one major 
change in mRNPs after deadenylation is the loss of PABPs, one 
important implication of our observations is that PABPs play 
an inhibitory role and prevent mRNPs from joining existing 
P-bodies or nucleating P-body formation in mammalian cells. 
It is plausible that the 3  poly(A) tail of an mRNA must fi rst 
be shortened, not only to permit dissociation of PABPs or factors 
that are important for effi cient translation of the mRNP but also 
to allow joining of translation repressors or other P-body com-
ponents to the mRNP. 
 P-bodies play differential roles in mRNA 
turnover and are not required for all mRNA 
decay pathways in mammalian cells 
 A central issue concerns whether all mRNA decay requires 
P-bodies. Our results ( Fig. 3 ) show that knocking down Pan3, a 
manipulation that has little effect on deadenylation but signifi -
cantly reduces P-bodies, slows decay of BBB+PTC mRNA but 
not BBB+ARE or BBB mRNA, supporting a differential in-
volvement of P-bodies in mammalian mRNA decay. These re-
sults are consistent with observations that several NMD-required 
factors can accumulate in P-bodies in yeast and  D. melanogaster 
( Barbee et al., 2006 ;  Sheth and Parker, 2006 ;  Eulalio et al., 2007a ) 
and that knocking down GW182 effectively abolishes P-bodies 
but has little effect on ARE-mediated decay in some human 
cells ( Stoecklin et al., 2006 ). Thus, even though decay of ARE-
containing mRNAs could involve or occur in P-bodies ( Ferraiuolo 
et al., 2005 ;  Franks and Lykke-Andersen, 2007 ), ARE-mediated 
decay does not always require P-bodies. 
 Our fi nding that reduction of P-bodies by Pan3 knockdown 
enhances the decay of BBB and BBB+ARE mRNAs ( Fig. 3 ) 
suggests a possible role for P-bodies in preventing mRNAs from 
degradation. In this case, P-bodies provide a storage site for 
mRNAs before they are degraded or reenter translatable pool (for 
reviews see  Eulalio et al., 2007b ;  Kedersha and Anderson, 2007 ; 
 Parker and Sheth, 2007 ). On the other hand, for aberrant mRNAs, 
such as PTC-containing transcripts, sequestration in P-bodies may 
provide a rapid means to prevent accidental translation before 
degradation. Collectively, our results indicate that P-bodies play 
differential roles in mammalian mRNA turnover and are not 
required for all mRNA decay pathways in mammalian cells. 
 Pan3 and Caf1 have distinct roles in 
mammalian mRNA turnover 
 Mammalian deadenylation is mediated by a concerted action 
of Pan2 – Pan3 and Ccr4 – Caf1 poly(A) nuclease complexes 
In contrast, Pan3 knockdown results in P-body reduction ( Fig. 3 A ) 
but has little or no impairing effect on deadenylation ( Fig. 3 B ). 
These results show that blocking deadenylation impairs P-body 
formation but that the converse is not true, thereby establishing 
the cause – effect relationship between deadenylation blockage and 
P-body loss. Second, the inhibitory effects of a dominant-negative 
mutant of Caf1 on deadenylation and P-body formation ( Figs. 6, 7 , 
and S4) demonstrate that P-body loss caused by knocking down 
deadenylation factors is because of deadenylation blockage 
by  itself and not simply because of the absence of the protein 
molecules that may be physically important for P-body integ-
rity. Importantly, coexpression of wild-type Ccr4 with the Caf1 
mutant, a situation in which deadenylation blockage is released 
( Fig. 6 C , bottom, middle), allows P-body formation ( Fig. 7 B , 
left). Third, puromycin, which increases the pool of nontranslat-
able mRNAs, induces P-body formation only when deadenyl-
ation is not blocked ( Fig. 8 ). Thus, it appears that mRNPs in 
P-bodies represent poly(A)-shortened mRNAs regardless of how 
they arrived in P-bodies or what their future fate is. 
 Deadenylation may induce mRNP 
remodeling required for P-body formation 
 Several observations in this study suggest that an mRNP con-
taining a poly(A)-shortened mRNA undergoes remodeling be-
fore it appears in P-bodies. First, Pan2 – Pan3 and Ccr4 – Caf1 
complexes can interact with each other in vivo ( Fig. 4 ), suggest-
ing that they form a super complex to direct the two consecutive 
phases of deadenylation in a concerted manner ( Yamashita 
et al., 2005 ) and to elaborate subsequent mRNP remodeling. 
This notion is further supported by our observation that over-
expression of the Caf1 mutant impaired both the fi rst and the 
second phases of deadenylation ( Fig. 6 ). It appears that the two 
 Figure 8.  Puromycin treatment does not induce P-body formation when 
deadenylation is impaired. (A) Puromycin treatment enhances P-body for-
mation (top, right) in NIH3T3 cells but does not induce P-body formation 
when Caf1 is knocked down (bottom, right). The cells transfected with either 
the control nonspeciﬁ c siRNA (top) or Caf1 siRNA (bottom) were treated 
with (right) or without (left) puromycin for 1 h. Endogenous GW182 was 
used as a marker to visualize P-bodies. (B) Puromycin treatment does not 
induce P-body formation in cells overexpressing the mutant Caf1 (bottom, 
right, dashed line). NIH3T3 cells were transfected with plasmids encoding 
either wild-type (top) or mutant (bottom) Caf1 followed by puromycin treat-
ment for 1 h. Immunoﬂ uorescence staining was performed as described 
in Materials and methods. Endogenous Dcp1a was used as a marker to 
visualize P-bodies. Bars, 15  μ m. 
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mutant promotes the formation of functional deadenylase com-
plexes because the deadenylase activity of the wild-type pro-
tein can complement its partner in the same complex. In contrast, 
HA-Ccr4 mutant and HA-Caf1 mutant cannot form a func-
tional deadenylase complex with each other, as both mutants 
are catalytically inactive. It is worth noting that although Caf1 
knockdown severely impairs mRNA deadenylation and decay 
( Fig. 5 ), Ccr4 knockdown only modestly affects the second phase 
of deadenylation without signifi cantly impairing overall mRNA 
decay ( Yamashita et al., 2005 ). Therefore, the role of Caf1 in 
mammalian turnover is distinct from that of Ccr4 and is more 
signifi cant than previously recognized. 
 A model linking deadenylation, P-bodies, 
and mRNA decay 
 Based on previous and the current fi ndings, we envisage the fol-
lowing scenario for deadenylation, P-body formation, and dif-
ferential mRNA decay in mammalian cells ( Fig. 9 ). [ID]FIG9[/ID] Pan2 – Pan3 
and Ccr4 – Caf1 complexes fi rst form a super complex on mRNAs 
in the cytoplasm. The 3  poly(A) tail – PABP complex then stim-
ulates poly(A) shortening by the Pan2 – Pan3 in the super com-
plex but inhibits the activity of Ccr4 – Caf1 ( Tucker et al., 2002 ), 
allowing the fi rst phase of deadenylation to proceed. mRNP re-
modeling occurs during or after the fi rst phase of deadenylation. 
Remodeling might involve dissociation of PABPs and some 
translation initiation factors and association of translation re-
pressors ( Coller and Parker, 2005 ; for reviews see  Eulalio et al., 
2007b ;  Parker and Sheth, 2007 ) to promote the transition of 
mRNPs to a nontranslatable state. A remodeled mRNP may as-
sociate with existing P-bodies or nucleate formation of new 
P-bodies, in which the second phase of deadenylation by Ccr4 –
 Caf1 and/or decapping would proceed. For some mRNPs, such 
as a PTC-mRNP, this process may take place with the help of 
Pan3. Sequestration within P-bodies at this point may provide a 
( Yamashita et al., 2005 ). Although knocking down Pan3 has lit-
tle effect on the fi rst phase of deadenylation ( Fig. 3 B ), Pan3 ap-
pears to play a role in modulating the activity of Pan2 or linking 
deadenylation to subsequent decay of the mRNA body. This no-
tion is supported by the observations that ectopic overexpres-
sion of Pan2 alone results in highly rapid and processive poly(A) 
shortening of the otherwise stable BBB mRNA ( Yamashita 
et al., 2005 ) and that the deadenylation and decay kinetics of a 
BBB transcript in cells coexpressing Pan2 and Pan3 are similar 
to those observed in cells not overexpressing these two factors 
(unpublished data). Moreover, we show in this paper that Pan3 
knockdown enhances the decay of BBB and BBB+ARE mRNAs 
( Fig. 3 B , middle [right] and bottom [right]). Together with the 
newly discovered roles for Pan3 in P-body formation ( Figs. 1, 2, 
and 3 ), our fi ndings offer an explanation as to why this evolu-
tionarily highly conserved protein is not required for deadenyl-
ation per se ( Tucker et al., 2001 ;  Temme et al., 2004 ;  Molin and 
Puisieux, 2005 ). 
 Unlike Pan3, Caf1 is indispensable for mammalian de-
adenylation. Knocking down Caf1 or overexpressing a Caf1 domi-
nant-negative mutant blocks deadenylation and stabilizes the 
transcripts ( Figs. 5 and 6 ). Although Caf1 and Ccr4 each exhibit 
poly(A) nuclease activity, these two proteins associate with each 
other and function as a poly(A) nuclease complex in vivo ( Tucker 
et al., 2002 ;  Temme et al., 2004 ;  Behm-Ansmant et al., 2006 ). 
Our data show that the poly(A) nuclease activities of Ccr4 
and Caf1 in the Ccr4 – Caf1 complex have complementary roles 
in mammalian deadenylation ( Fig. 6 C ). Overexpression of the 
Caf1 catalytically mutant alone or the Ccr4 mutant alone inter-
feres with the normal deadenylation function of the Ccr4 – Caf1 
complex because these mutants have a dominant-negative effect 
that overrides the activity of endogenous deadenylase complexes. 
Overexpression of both HA-Ccr4 wild-type and HA-Caf1 mu-
tant or overexpression of both HA-Caf1 wild-type and Ccr4 
 Figure 9.  A model linking deadenylation, 
P-bodies, and mRNA decay. See Discussion 
for details. 
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DNA containing 0.055  μ g of reporter plasmid, 0.11  μ g of internal control 
plasmid, and 2.13  μ g of DNA encoding HA-tagged proteins. The mixture 
was incubated at RT for 25 min, added to the culture dish, and incubated 
at 37 ° C (8% CO 2 ) for 42 h. Time-course experiments using the Tet-off sys-
tem for transcriptional pulsing were performed as described previously 
( Chen et al., 2007 ). 
 Preparation of RNA samples and Northern blot analysis 
 Isolation of cytoplasmic RNA, preparation of probes, and Northern blot 
analysis were conducted as described previously. In brief, at various time 
points after the transcription pulse driven by the Tet-off promoter of the re-
porter plasmid in transfected cells, cytoplasmic mRNA was isolated using 
the cytoplasmic lysis buffer RLN (50 mM Tris-HCl, pH 8, 140 mM NaCl, 
1.5 mM MgCl 2 and 0.5% NP-40) and RNeasy Mini kit (QIAGEN). 15  μ g 
RNAs were then separated using 1.4% formaldehyde agarose gel electro-
phoresis and then transferred to GeneScreen Hybridization Transfer mem-
brane (PerkinElmer) and blotted with a  32 P-labeled gene-speciﬁ c DNA 
probe using ULTRAhyb hybridization buffer (Ambion). Gene-speciﬁ c DNA 
probes were prepared by the Rediprime II Random Prime Labeling System 
(GE Healthcare). The  32 P-labeled probes were produced by inclusion of 
  -[ 32 P]dCTP ( > 6000 Ci/mmol; PerkinElmer). RNase H treatment of cyto-
plasmic mRNA after annealing to Oligo dT (Invitrogen) was used to gener-
ate poly(A)  –  RNA as described previously ( Shyu et al., 1991 ). All the 
time-course experiments were repeated at least twice. 
 Western blot analysis and immunoprecipitation 
 Cytoplasmic and nuclear lysates were prepared as described previously 
( Peng et al., 1998 ). Total cell lysates (5 – 40  μ g) were resolved on a 7 or 
10% SDS-polyacrylamide gel and analyzed using an ECL Western blot-
ting kit (GE Healthcare). The PVDF blots were probed with speciﬁ c anti-
bodies as indicated in each ﬁ gure and detected with SuperSignal West 
Pico Chemiluminescent Substrate (Thermo Fisher Scientiﬁ c). Membranes 
were incubated with one of the primary antibodies at the indicated dilu-
tion: HRP-conjugated monoclonal Anti-V5 antibody at 1:5,000 (Invitro-
gen); HRP-conjugated monoclonal anti-HA antibody at 1:1,000 (Roche); 
rat anti-HA monoclonal antibody at 1:4,000 (Roche); mouse anti –  -tubulin 
monoclonal antibody at 1:10,000 (Sigma-Aldrich); rabbit anti-Dcp1a 
 serum at 1:4,000 (Bethyl Laboratories, Inc. or gift from S. Ohno); rabbit 
anti-Rck/p54 serum at 1:1,000 (Bethyl Laboratories, Inc.); mouse mono-
clonal antibody against GAPDH at 1:10,000 (Research Diagnostics, 
Inc.); and mouse antibody against lamin A/C at 1:1,000 (Santa Cruz 
Biotechnology, Inc.). To detect endogenous Caf1, Pan2, and Pan3 in 
mouse NIH3T3 or monkey COS7 cells, the corresponding polyclonal an-
tibodies were generated in rabbits immunized with gene-speciﬁ c pep-
tides using the custom antibody service from Bethyl Laboratories, Inc. 
Afﬁ nity-puriﬁ ed anti-peptide antibodies were used at the following dilu-
tions: rabbit anti-Pan3 peptide antibody at 1:2,000; rabbit anti-Caf1 
peptide at 1:1,000; or rabbit anti-Pan2 peptide at1:2,000. Rabbit anti-
PABP antibody (gift from R. Lloyd, Baylor College of Medicine, Houston, 
TX) was used at a 1:4,000 dilution. HRP-conjugated donkey anti – rabbit 
IgG antibodies (1:4,000; GE Healthcare) or goat anti – mouse (1:5,000; 
Bio-Rad Laboratories) were used as secondary antibodies for detection 
with a chemiluminescence reagent (peroxide/luminol enhancer; Thermo 
Fisher Scientiﬁ c). 
 For coimmunoprecipitation, COS7 cells expressing HA-Pan2, Ccr4-
V5, HA-Pan3, or V5-Pan3 were lysed at 48 h after transfection by incubat-
ing for 10 min at 4 ° C in 600  μ l of lysis buffer (20 mM Tris – HCl buffer, 
pH 7.4, containing 150 mM NaCl, 1% NP-40, 1 mM Na orthovanadate, 
1 mM Na pyrophosphate, and 1 mM NaF supplemented with a protease 
inhibitor cocktail [Roche]). 50  μ l of cell lysate was preserved as input, and 
the remainder was incubated with a monoclonal anti – V5-agarose conju-
gate (Sigma-Aldrich) or a rat monoclonal anti-HA Afﬁ nity Matrix (Roche) in 
the presence of 0.1  μ g/ml RNase A. Immunoprecipitations were performed 
at 4 ° C for 4 h. The beads were washed ﬁ ve times with the lysis buffer. 
 Coprecipitated proteins were detected by Western blotting using the 
indicated antibodies. The protein samples were separated by 7 – 10% 
SDS-PAGE and analyzed by Western blot analysis as described in the pre-
vious paragraph. 
 Immunoﬂ uorescence microscopy 
 NIH3T3 cells were seeded in 6-well plates at a density of 0.4  × 10 6 cells 
per well, 24 h before transfection using Lipofectamine 2000 (Invitrogen). 
At 22 – 26 h after transfection, cells were reseeded to slide chambers 
(BD Biosciences) and incubated overnight. For cycloheximide, puromy-
cin, or arsenite treatment, cells were incubated in media containing either 
quick means of keeping aberrant mRNPs, such as PTC-mRNPs, 
from being translated before their poly(A) tail or cap is removed 
and the RNA body degraded. Alternatively, a remodeled mRNP 
may undergo the second phase of deadenylation outside of 
P-bodies, which could induce another mRNP remodeling that 
determines whether the oligo(A)-mRNP would be degraded in-
side or outside of P-bodies. 
 The observation that four component proteins of the two 
major poly(A) nuclease complexes can be found in mamma-
lian P-bodies links all major mRNA decay factors except the 
3  exosome complex to P-bodies. The present results argue 
for a biological role for P-bodies in coupling deadenylation 
and mRNP remodeling to translation repression in an effective 
manner. One important conclusion from our fi ndings in this 
study is that although P-bodies may be assembled via different 
mechanisms, deadenylation is always a necessary step that 
enables mRNPs to enter existing P-bodies or to initiate the 
formation of P-bodies. It will be interesting to see how knock-
down of Pan3 or Caf1 or overexpression of the Caf1 dominant-
negative mutant might impact different posttranscriptional 
mechanisms regulating mammalian mRNA expression, such as 
those mediated by miRNAs, whose functions were found to be 
linked to P-bodies ( Jackson and Standart, 2007 ;  Nilsen, 2007 ; 
 Pillai et al., 2007 ; for reviews see  Eulalio et al., 2007b ;  Parker 
and Sheth, 2007 ). 
 Materials and methods 
 Plasmids 
 To construct a plasmid encoding HA-tagged Pan3 or Caf1, a 2.2-kb Pan3L 
cDNA ampliﬁ ed by RT-PCR from human testis total RNA (Clontech Labora-
tories, Inc.) or an 855-bp fragment encoding Caf1 ampliﬁ ed from IMAGE 
clone 6207987 was inserted between the EcoRV and XhoI sites of pSRHi-
sHA (gift from S. Ohno, Yokohama City University, Yokohama, Japan; 
Kashima et al., 2006). The Caf1 cDNA was inserted between the HindlII 
and XbaI sites of pcDNA6/V5-HisA (Invitrogen) to generate pcDNA6-
Caf1-V5. A plasmid encoding catalytic inactive Caf1 mutant (D40A) was 
created using the QuikChange site-directed mutagenesis kit (Stratagene) 
with pSR-HA-Caf1 as the template. To construct pcDNA6-Pan2-V5, a 3.6-kb 
Pan2 cDNA was ampliﬁ ed from IMAGE clone 3357890 and inserted be-
tween the Aﬂ II and XbaI sites of pcDNA6/V5-HisA (Invitrogen). To gener-
ate myc-PABP, the coding region of PABP was ampliﬁ ed by PCR from 
GST-PABP (Chang et al., 2004) and inserted between the XmaI and XhoI 
sites of SRmyc (gift from S. Ohno). GFP-Dcp1a and GFP-Ccr4 (gifts from 
B. Seraphin, Centre de G é n é tique Mol é culaire, Gif sur Yvette Cedex, France) 
were described previously ( Eystathioy et al., 2003 ). Construction of all 
other plasmids used in this study has been described previously ( Xu et al., 
1998 ;  Chen and Shyu, 1994, 2003 ;  Loﬂ in et al., 1999a ;  Chang et al., 
2004 ;  Yamashita et al., 2005 ). 
 Cell culture and transfection 
 Either Lipofectamine 2000 (Invitrogen) or FuGENE 6 (Roche) was used for 
transient transfections. NIH3T3 B2A2 cells were split to a density of 2.6  × 
10 6 /10 cm dish 24 h before transfection in 100 ng/ml tetracycline. 40  μ l 
Lipofectamine 2000 and 1.5 ml Opti-MEM were mixed well and incubated 
for 5 min at RT. DNA (1.3  μ g of reporter plasmid and 1.3  μ g of internal 
control plasmid, pSV –  -globin – GAPDH) and siRNA (4.86  μ g of nonspe-
ciﬁ c siRNA or Pan3 siRNA, or 2.43  μ g Caf1 siRNA plus 2.43  μ g Pop2 
siRNA [SMARTpool; Thermo Fisher Scientiﬁ c]) were diluted into 1.5 ml 
Opti-MEM, added to the Lipofectamine 2000 mixture, and incubated at RT 
for 25 min. The ﬁ nal mixture was then added to the cells in a 10-cm dish 
and incubated at 37 ° C (5% CO 2 ). Cells were split 18 h later into 6-cm 
dishes (1.5  × 10 6 /6 cm dish) and incubated at 37 ° C (8% CO 2 ) for 24 h. 
When using FuGENE 6, NIH3T3 B2A2 cells were split to a density of 0.65  × 
10 6 /6 cm dish 24 h before transfection in the presence of 50 ng/ml tetra-
cycline. 6.9  μ l FuGENE 6 was diluted in 100  μ l DME and mixed with 2.3  μ g 
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7.5  μ g/ml cycloheximide (Sigma-Aldrich) for 2 h, 100  μ g/ml puromycin 
(Sigma-Aldrich) for 1 h, or 0.3 mM sodium arsenite (Sigma-Aldrich) for 1 h 
before ﬁ xation. Cells in the slide chambers were ﬁ xed for 10 min each 
with 3.7% (wt/vol) PFA (Sigma-Aldrich) in PBS and then with cold metha-
nol, followed by a 10-min incubation in 0.2% (vol/vol) Triton X-100 in 
PBS. Each microgram of Zenon-labeled antibodies (see third paragraph 
in this section) was diluted in 500  μ l of 1% BSA in PBS and incubated 
with the ﬁ xed slides. After incubating for 1 h at RT and washing, the 
slides were ﬁ xed again in 3.7% PFA. For indirect immunoﬂ uorescence 
microscopy, all of the primary and secondary antibodies, except the 
mouse anti-myc serum, were diluted 1:1,000 with 1% (wt/vol) BSA in 
PBS. Endogenous Pan2 was detected using rabbit anti-Pan2 labeled with 
Zenon 555 rabbit IgG labeling reagent. Endogenous Dcp1a, Xrn1, or 
Pan3 was detected using rabbit anti-Dcp1a, anti-Xrn1, or anti-Pan3 la-
beled with Zenon 488 rabbit IgG labeling reagent. HA-tagged Pan3, 
Ccr4, or Caf1 was detected using rat anti-HA monoclonal antibody and 
Alexa Fluor 350 goat anti – rat IgG. HA-Pan2 or V5-tagged proteins were 
detected using rat monoclonal anti-HA or mouse monoclonal anti-V5 and 
Alexa Flour 555 goat anti – rat IgG. Rabbit anti-Xrn1 antibody was a gift 
from J. Lykke-Andersen (University of Colorado at Boulder, Boulder, CO), 
human anti-GW182 antiserum was a gift from M.J. Fritzler (University of 
Calgary, Calgary, Canada), rabbit anti-G3BP1 was a gift from R. Lloyd, 
and rabbit anti-Dcp1a antibody was a gift from S. Ohno. The mouse anti-
myc monoclonal antibody from culture medium collected from anti-myc 
monoclonal antibody secreting hybridoma cells (American Type Culture 
Collection) was used at 1:50 dilution. After incubation with the indicated 
primary antibodies/sera, cells were washed three times in PBS for 5 min 
and incubated with ﬂ uorescently labeled secondary antibodies (Invitro-
gen) as indicated in the ﬁ gures. Fluorescence mounting medium with or 
without DAPI was added. 
 Images were obtained at RT by optical z-sectioning (20 sections in 
total, 0.2- μ m-space between sections) using an objective lens (100 × /1.35 
NA; Olympus) of a deconvolution microscope system (DeltaVision) contain-
ing an inverted microscope (IX70; Olympus). Immersion oil ( n = 1.514) 
was from Applied Precision, LLC. Images were captured using a digital 
camera (Coolsnap HQ; Roper Scientiﬁ c). Stacks of 20 images were pro-
jected as a single 2D picture using softWoRx Explorer (version 3.3.6; 
 Applied Precision, LLC). The RGB colors of the resulting pictures were sepa-
rated using Photoshop CS (Adobe). 
 When two different primary antibodies raised in rabbits were used 
together to visualize P-bodies, the following procedure was used. One  μ g 
of rabbit antibody was incubated for 5 min at RT with 5  μ l Zenon rabbit 
IgG labeling reagent, either Alexa Flour 488- or 555-labeled Fab frag-
ment (Invitrogen). The labeled Fab fragment was bound to the Fc portion 
of the rabbit IgG, and excess Fab fragment was neutralized by the addi-
tion of 5  μ l of nonspeciﬁ c rabbit IgG, which prevented cross-labeling of 
the Fab fragment when two rabbit antibodies were used. After a 5-min 
incubation at RT, the labeled antibodies were used for staining in combi-
nation with each other or with labeled secondary antibodies speciﬁ c for 
other species. To analyze the changes in P-body number and size after 
Pan3 knockdown, 87 cells transfected with control nonspeciﬁ c siRNA 
and 91 cells transfected with Pan3 siRNA were analyzed using ImageJ 
software (pixel range for particle brightness between 40 and 215; 
 National Institutes of Health). Dcp1a particles with values  > 50 square 
pixels were considered above background staining and were selected 
for P-body analysis. 
 Online supplemental material 
 Fig. S1 shows detection of P-bodies in NIH3T3 cells. Fig. S2 demonstrates 
that HA-Pan3 foci are P-bodies and not stress granules. Fig. S3 shows that 
Pan3 does not help PABP localize to P-bodies. Fig. S4 shows that over-
expression of catalytically inactive mutant Caf1 blocks P-body formation in 
monkey COS7 cells. Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.200801196/DC1. 
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